Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 571 (ZNF571) is a member of the zinc finger protein family, which functions primarily as DNA-binding transcription factors involved in the regulation of transcription by RNA polymerase II[2][3][5]. ZNF571 is a protein-coding gene located in the nucleus and is predicted to enable RNA polymerase II-specific, cis-regulatory region sequence-specific DNA binding activity, though its precise biological functions, roles in disease, and suitability as a therapeutic target are not well-characterized in current literature[2][3][5][7]. While zinc finger proteins in general play important roles in gene regulation, cell differentiation, immune responses, apoptosis, and have been implicated in several cancers, there are currently no data linking ZNF571 specifically to diseases, drug interactions, or use as a biomarker in patient selection or efficacy monitoring[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 571 (ZNF571).